Old Articles: <Older 9141-9150 Newer> |
|
Chemistry World August 26, 2015 Andrea McGhee |
How could a tree make tramadol? Researchers in France, Switzerland and Cameroon are convinced that the African pin-cushion tree produces the well-known painkiller Tramadol and are determined to prove it. |
Chemistry World August 21, 2015 Sa njay Kumar |
Indian pharma under increased regulatory scrutiny A Europe-wide ban on hundreds of generic pharmaceutical formulations tested by Indian contract research firm GVK Biosciences comes into force today. |
Fast Company Sarah Lawson |
Google X's Life Sciences Team Will Become Its Own Company Under Alphabet Last year, that team developed a smart contact lens that helped diabetics painlessly monitor their glucose levels, among other things. |
Chemistry World August 20, 2015 Andy Extance |
Porous pills could be largest industrial 3D printing use The first ever approval by the US Food and Drug Administration of a 3D printed tablet promises to make medications easier to swallow than existing formulations. |
Chemistry World August 17, 2015 Anthony King |
Greek crisis puts pressure on pharmaceuticals Supplies of critical drugs to Greek pharmacies have become sparse and erratic as the economic crisis squeezes public spending |
Chemistry World August 14, 2015 Jennifer Newton |
No one should be denied medication 'My whole fight today, for the third world, is for access to medicine at affordable prices,' attests Indian generics manufacturer Cipla chairman Yusuf Hamied. |
Information Today August 11, 2015 |
Thomson Reuters Rolls Out Pharmaceutical R&D Factbook The 2015 CMR International Pharmaceutical R&D Factbook shows global R&D trends for the biopharmaceutical industry. |
Chemistry World August 10, 2015 Rebecca Trager |
Shire makes hostile bid for Baxalta Baxalta rejected Shire's initial private offer in July 2015, and the same outcome appears likely this time around. |
HBS Working Knowledge August 10, 2015 Michael Blanding |
New Medical Devices Get To Patients Too Slowly The FDA has streamlined drug testing to ensure new therapies come to market quickly. But when it comes to life-giving medical devices, approvals seem unnecessarily slow, according to research by Ariel Dora Stern. |
Chemistry World August 5, 2015 Rebecca Trager |
Grabbing slices of the immuno-oncology pie An increasing number of companies are competing for a slice of the immuno-oncology market |
<Older 9141-9150 Newer> Return to current articles. |